SAN DIEGO, CA / ACCESS Newswire<https://www.accessnewswire.com/> / November 4, 2026 / Blue Magic Ventures by General Atomics Aeronautical Systems, Inc. (GA-ASI) returns on November 17 for the next...

If approved, BRUKINSA plus rituximab would be the first and only chemotherapy-free, BTK inhibitor-based regimen for adult patients with previously untreated mantle cell lymphoma Application...

Explore around 700 knives and accessories; meet three Echizen bladesmiths KOBE, Japan--BUSINESS WIRE-- HOCHO KNIFE, a Japanese kitchen knife specialist that has delivered more than 200,000...

This framework agreement provides all entities subject to the French Public Procurement Code with simplified access to a support alternative enabling them to control their costs, preserve their...

CHENGDU, China--BUSINESS WIRE-- Chengdu Zenitar Biomedical Technology Co., Ltd. (Zenitar) is developing flonoltinib maleate (FM), a first-in-class oral JAK2/FLT3/CDK6 inhibitor for...

DALLAS & OSS, Netherlands--BUSINESS WIRE-- Trained Therapeutix Discovery ("TTxD"), a pioneering immunotherapy company founded by the Jean Boulle Group and the Heritage Group, which is developing...

MariaDB Enterprise Platform 2027 brings 56% higher throughput, more resilience and new AI capabilities to one durable foundation, and a new brand identity marks the company’s evolution from...

New collaboration enhances customer access to plant proteins, fibers, and cellulosics, driving innovation in health and nutrition markets [GettyImages-2041034770...

DUNHUANG, China, Nov. 4, 2026 / Xinhua-AsiaNet / -- The 9th Silk Road (Dunhuang) International Cultural Expo opened in Dunhuang, Gansu on November 3, bringing together Chinese and foreign guests...

61% of firms now embed regulatory change within a year, up from 26% in 2025, yet confidence in compliance outcomes has fallen from 59% to 45% LONDON, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Firms are...